Plasma sIL-2Rα levels are associated with disease progression in myelofibrosis with JAK2V617F but not CALR mutation

Giovanni Barosi; Rita Campanelli; Paolo Catarsi; Mara De Amici; Carlotta Abbà; Gianluca Viarengo; Laura Villani; Robert P. Gale; Vittorio Rosti; Margherita Massa

doi:10.1016/j.leukres.2020.106319

Plasma sIL-2Rα levels are associated with disease progression in myelofibrosis with JAK2^V617F but not CALR mutation

Giovanni Barosi, Rita Campanelli, Paolo Catarsi, Mara De Amici, Carlotta Abbà, Gianluca Viarengo, Laura Villani, Robert P. Gale, Vittorio Rosti, Margherita Massa

IRCCS Fondazione Policlinico San Matteo

Research output: Contribution to journal › Letter › peer-review

Original language	English
Article number	106319
Journal	Leukemia Research
Volume	90
DOIs	https://doi.org/10.1016/j.leukres.2020.106319
Publication status	Published - Mar 2020

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1016/j.leukres.2020.106319

Cite this

Plasma sIL-2Rα levels are associated with disease progression in myelofibrosis with JAK2^V617F but not CALR mutation. / Barosi, Giovanni; Campanelli, Rita ; Catarsi, Paolo ; De Amici, Mara; Abbà, Carlotta; Viarengo, Gianluca ; Villani, Laura; Gale, Robert P.; Rosti, Vittorio ; Massa, Margherita.

In: Leukemia Research, Vol. 90, 106319, 03.2020.

Research output: Contribution to journal › Letter › peer-review

@article{633a7821d21849b08280a38181da7127,

title = "Plasma sIL-2Rα levels are associated with disease progression in myelofibrosis with JAK2V617F but not CALR mutation",

author = "Giovanni Barosi and Rita Campanelli and Paolo Catarsi and {De Amici}, Mara and Carlotta Abb{\`a} and Gianluca Viarengo and Laura Villani and Gale, {Robert P.} and Vittorio Rosti and Margherita Massa",

year = "2020",

month = mar,

doi = "10.1016/j.leukres.2020.106319",

language = "English",

volume = "90",

journal = "Leukemia Research",

issn = "0145-2126",

publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - Plasma sIL-2Rα levels are associated with disease progression in myelofibrosis with JAK2V617F but not CALR mutation

AU - Barosi, Giovanni

AU - Campanelli, Rita

AU - Catarsi, Paolo

AU - De Amici, Mara

AU - Abbà, Carlotta

AU - Viarengo, Gianluca

AU - Villani, Laura

AU - Gale, Robert P.

AU - Rosti, Vittorio

AU - Massa, Margherita

PY - 2020/3

Y1 - 2020/3

UR - http://www.scopus.com/inward/record.url?scp=85079586436&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85079586436&partnerID=8YFLogxK

U2 - 10.1016/j.leukres.2020.106319

DO - 10.1016/j.leukres.2020.106319

M3 - Letter

AN - SCOPUS:85079586436

VL - 90

JO - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

M1 - 106319

ER -

Plasma sIL-2Rα levels are associated with disease progression in myelofibrosis with JAK2V617F but not CALR mutation

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this

Plasma sIL-2Rα levels are associated with disease progression in myelofibrosis with JAK2^V617F but not CALR mutation